1256-AI Prediction of Prostate Cancer Molecular Subtypes

Researchers have developed an advanced AI framework designed to identify prostate cancer molecular subtypes directly from standard, low-cost histology slides. By fine-tuning a pathology-based foundational model, this technology accurately predicts genetic classifications that typically require expensive and time-consuming transcriptomic testing. The study demonstrates that these AI-derived scores correlate with how well a patient might respond to hormonal therapy and the likelihood of discovering aggressive disease during surgery. Specifically, tumors identified as luminal B or proliferating subtypes showed a higher sensitivity to treatment but also a stronger association with adverse pathologic features. Ultimately, this digital approach provides a scalable alternative for personalized risk assessment and treatment planning in clinical settings. This breakthrough bridge between computational pathology and genomics could significantly enhance global access to precision medicine for prostate cancer patients.References:Nateghi R, Sun A, Dang H, et al. Prediction of molecular subtypes from histology: AI-driven analysis of prostate cancer morphological patterns and therapeutic implications[J]. npj Precision Oncology, 2026.前往小宇宙评论区与主播互动